Drug Trial Radar · NCT00942331
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Last checked: Nov 19, 2026Latest source record: Jun 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
506
Actual
Start
Jul 15, 2009
Primary completion
Nov 2, 2018
Study completion Jun 15, 2021
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Jul 20, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase III trial studies gemcitabine hydrochloride, cisplatin, and bevacizumab to see how well they work compared with gemcitabine hydrochloride and cisplatin in treating patients with urinary tract cancer that has spread to other places in the body. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with bevacizumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. It is not yet known whether gemcitabine hydrochloride and cisplatin are more effective when given with or without bevacizumab in treating patients with urinary tract cancer.
Conditions
- Advanced Urothelial Carcinoma
- Metastatic Bladder Urothelial Carcinoma
- Metastatic Prostate Carcinoma
- Metastatic Renal Pelvis Urothelial Carcinoma
- Metastatic Ureter Urothelial Carcinoma
- Metastatic Urethral Urothelial Carcinoma
- Metastatic Urothelial Carcinoma
- Stage IV Bladder Urothelial Carcinoma AJCC v7
- Stage IV Prostate Cancer AJCC v7
- Stage IV Renal Pelvis Cancer AJCC v7
- Stage IV Ureter Cancer AJCC v7
- Stage IV Urethral Cancer AJCC v7
- Unresectable Urothelial Carcinoma
Interventions
BevacizumabBiological
Given IV
CisplatinDrug
Given IV
Gemcitabine HydrochlorideDrug
Given IV
Laboratory Biomarker AnalysisOther
Correlative studies
Placebo AdministrationOther
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: From date of randomization to date of death due to any cause, assessed up to 7 years
Locations
873 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Providence Hospital
Mobile, Alabama
Fairbanks Memorial Hospital
Fairbanks, Alaska
University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
University of Arizona Cancer Center-North Campus
Tucson, Arizona
Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas
John L McClellan Memorial Veterans Hospital
Little Rock, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Mills-Peninsula Medical Center
Burlingame, California
East Bay Radiation Oncology Center
Castro Valley, California
Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California
Community Cancer Institute
Clovis, California
John Muir Medical Center-Concord Campus
Concord, California
Bay Area Breast Surgeons Inc
Emeryville, California
Epic Care Partners in Cancer Care
Emeryville, California
Valley Medical Oncology Consultants-Fremont
Fremont, California
Marin Cancer Care Inc
Greenbrae, California
Marin General Hospital
Greenbrae, California
UC San Diego Moores Cancer Center
La Jolla, California
Los Angeles County-USC Medical Center
Los Angeles, California
USC / Norris Comprehensive Cancer Center
Los Angeles, California
Contra Costa Regional Medical Center
Martinez, California
Memorial Medical Center
Modesto, California
El Camino Hospital
Mountain View, California
Palo Alto Medical Foundation-Camino Division
Mountain View, California
Northridge Hospital Medical Center
Northridge, California
Sutter Cancer Research Consortium
Novato, California
Highland General Hospital
Oakland, California
Alta Bates Summit Medical Center - Summit Campus
Oakland, California
Bay Area Tumor Institute
Oakland, California
Hematology and Oncology Associates-Oakland
Oakland, California
Tom K Lee Inc
Oakland, California
Saint Joseph Hospital - Orange
Orange, California
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California
Palo Alto Medical Foundation Health Care
Palo Alto, California
Stanford Cancer Institute Palo Alto
Palo Alto, California
Keck Medical Center of USC Pasadena
Pasadena, California
Valley Care Health System - Pleasanton
Pleasanton, California
Showing 40 of 873 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.